Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Editas Medicine (EDIT) Capital Leases (2016 - 2018)

Historic Capital Leases for Editas Medicine (EDIT) over the last 3 years, with Q4 2018 value amounting to $32.4 million.

  • Editas Medicine's Capital Leases fell 303.31% to $32.4 million in Q4 2018 from the same period last year, while for Dec 2018 it was $32.4 million, marking a year-over-year decrease of 303.31%. This contributed to the annual value of $32.4 million for FY2018, which is 303.31% down from last year.
  • Editas Medicine's Capital Leases amounted to $32.4 million in Q4 2018, which was down 303.31% from $32.7 million recorded in Q3 2018.
  • Editas Medicine's Capital Leases' 5-year high stood at $35.1 million during Q4 2016, with a 5-year trough of $11.6 million in Q1 2016.
  • For the 3-year period, Editas Medicine's Capital Leases averaged around $30.6 million, with its median value being $33.1 million (2018).
  • Data for Editas Medicine's Capital Leases shows a peak YoY increase of 19126.11% (in 2017) and a maximum YoY decrease of 474.41% (in 2017) over the last 5 years.
  • Quarter analysis of 3 years shows Editas Medicine's Capital Leases stood at $35.1 million in 2016, then decreased by 4.74% to $33.4 million in 2017, then fell by 3.03% to $32.4 million in 2018.
  • Its last three reported values are $32.4 million in Q4 2018, $32.7 million for Q3 2018, and $32.9 million during Q2 2018.